| scholarly article | Q13442814 |
| P2093 | author name string | Yiannis Ioannou | |
| Chris Wincup | |||
| P2860 | cites work | Lupus anticoagulant testing and anticoagulation do not mix: quantitation of discrepant results and potential approaches to reduce false positives | Q87415657 |
| The Role of TLR4 on B Cell Activation and Anti-β2GPI Antibody Production in the Antiphospholipid Syndrome | Q28069430 | ||
| Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals | Q28217805 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications | Q33328347 | ||
| Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood. | Q33329434 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| A family study of the antiphospholipid syndrome associated with other autoimmune diseases | Q33356141 | ||
| Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus | Q33358014 | ||
| Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? | Q33367182 | ||
| Neonatal thromboembolic emergencies | Q33370452 | ||
| Antiphospholipid syndrome and recurrent thrombosis in children | Q33373464 | ||
| Antiphospholipid antibodies in Turkish children with thrombosis | Q33375108 | ||
| Atypical haemolytic uremic syndrome complicated by microangiopathic antiphospholipid-associated syndrome | Q33380949 | ||
| Non-ST-elevation acute myocardial infarction secondary to antiphospholipid antibody syndrome in an adolescent female. | Q33393583 | ||
| Thrombotic microangiopathy due to multiple autoantibodies related to antiphospholipid syndrome | Q33398993 | ||
| Lupus anticoagulant testing | Q33406751 | ||
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients | Q33412915 | ||
| Differences in disease phenotype and severity in SLE across age groups | Q33431990 | ||
| Lupus pregnancy. A prospective study of placental changes | Q33447262 | ||
| Antiphospholipid antibodies in pediatric systemic lupus erythematosus | Q33487607 | ||
| Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives | Q33493079 | ||
| Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies. | Q33494142 | ||
| Antiphospholipid antibodies in pediatric lupus nephritis | Q33498510 | ||
| Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients | Q33502956 | ||
| Antibodies to serine proteases in the antiphospholipid syndrome | Q33670367 | ||
| Impaired fibrinolysis in the antiphospholipid syndrome | Q33822542 | ||
| Endothelial activation by aPL: a potential pathogenetic mechanism for the clinical manifestations of the syndrome | Q34021310 | ||
| Primary antiphospholipid syndrome presenting as complicated Henoch-Schönlein purpura | Q34517844 | ||
| Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches | Q35621012 | ||
| Thrombosis in systemic lupus erythematosus: a French collaborative study | Q35626838 | ||
| Inflammatory response and the endothelium. | Q35928642 | ||
| Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome | Q36037794 | ||
| European registry of babies born to mothers with antiphospholipid syndrome | Q36550832 | ||
| Ocular manifestations in antiphospholipid syndrome | Q36835138 | ||
| Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome | Q36915667 | ||
| Infant perinatal thrombosis and antiphospholipid antibodies: a review | Q36915670 | ||
| Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial | Q37230504 | ||
| Pediatric antiphospholipid antibodies and antiphospholipid syndrome | Q37249533 | ||
| Antiphospholipid antibodies and antiphospholipid syndrome in patients with malignancies: features, incidence, identification, and treatment | Q37249537 | ||
| How we diagnose the antiphospholipid syndrome | Q37255698 | ||
| Pathogenesis of antiphospholipid syndrome: understanding the antibodies | Q37873720 | ||
| Thrombophilia testing in neonates and infants with thrombosis | Q37915824 | ||
| Pathogenesis of the antiphospholipid syndrome | Q38003312 | ||
| Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab | Q38115382 | ||
| Update on the current recommendations and outcomes in pregnant women with antiphospholipid syndrome | Q38258585 | ||
| Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome | Q38297919 | ||
| Antiphospholipid Syndrome--Not a Noninflammatory Disease. | Q38567322 | ||
| MHC Class II Alleles influence Induction of Pathogenic Antiphospholipid Antibodies in a Thrombosis Mouse Model | Q38699947 | ||
| Genetic aspects of the antiphospholipid syndrome: An update | Q38709690 | ||
| What is known about pediatric antiphospholipid syndrome? | Q38951210 | ||
| European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative. | Q39284670 | ||
| Clinical characteristics of antiphospholipid antibody syndrome in children | Q39429926 | ||
| Infant with probable catastrophic antiphospholipid syndrome successfully managed with rituximab | Q39933698 | ||
| Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. | Q40032766 | ||
| Type III mixed cryoglobulinemia and antiphospholipid syndrome in a patient with partial DiGeorge syndrome. | Q40462581 | ||
| Dermatomyositis and polymyositis associated with the antiphospholipid syndrome-a novel overlap syndrome | Q40774311 | ||
| Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome; a case report and review of the literature | Q40980420 | ||
| Pediatric antiphospholipid syndrome | Q41100232 | ||
| Antiphospholipid antibody syndrome in pediatric patients. | Q41587414 | ||
| Antiphospholipid-mediated thrombosis: interplay between type of antibodies and localisation of lung, and cardiovascular incidences in primary antiphospholipid syndrome | Q41658166 | ||
| Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with 'seronegative' antiphospholipid syndrome | Q43090289 | ||
| Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the "CAPS Registry". | Q43456912 | ||
| Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo | Q43882937 | ||
| A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome | Q44588720 | ||
| Recurrent acute transverse myelopathy: association with antiphospholipid antibody syndrome | Q44958834 | ||
| Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients | Q45330654 | ||
| Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome? | Q45864129 | ||
| End-stage renal disease from glomerulonephritis associated with anti-phospholipid syndrome. | Q45961802 | ||
| Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients | Q47685633 | ||
| Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4. | Q48074369 | ||
| Laboratory tests for the antiphospholipid syndrome. | Q53095612 | ||
| Anticardiolipin and anti-beta(2) glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. | Q53325327 | ||
| Antiphospholipid syndrome | Q55891386 | ||
| IRF5 is associated with primary antiphospholipid syndrome, but is not a major risk factor | Q57461748 | ||
| Association ofSTAT4andBLK, but notBANK1orIRF5, with primary antiphospholipid syndrome | Q57461793 | ||
| Major histocompatibility complex associations with primary antiphospholipid syndrome | Q58143748 | ||
| An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions | Q59075500 | ||
| Estimation of Antiphospholipid Antibodies in a Prospective Longitudinal Study of Children with Migraine | Q61480456 | ||
| Thrombotic storm in a 4-year-old boy with a thrombus in the right atrium | Q64045349 | ||
| The catastrophic antiphospholipid syndrome | Q68136491 | ||
| Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant | Q71593361 | ||
| Antiphospholipid syndrome in young patients. Two cases of cerebral ischaemic accidents | Q71865537 | ||
| Fatal myocardial infarction in an 8-year-old girl with systemic lupus erythematosus, Raynaud's phenomenon, and secondary antiphospholipid antibody syndrome | Q72335507 | ||
| Primary antiphospholipid antibody syndrome and cardiac involvement in a child | Q73114412 | ||
| Positive direct antiglobulin test due to antiphospholipid antibodies in normal healthy blood donors | Q73327925 | ||
| Thrombosis associated with antiphospholipid antibody in juvenile chronic arthritis | Q73585774 | ||
| Outcome of primary antiphospholipid syndrome in childhood | Q73694057 | ||
| Antiphospholipid- associated recurrent chorea and ballism in a child with cerebral palsy | Q74238858 | ||
| Atypical renal onset and involvement in primary antiphospholipid syndrome in a child | Q74446836 | ||
| B cell depletion therapy for patients with systemic lupus erythematosus results in a significant drop in anticardiolipin antibody titres | Q81374489 | ||
| Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies | Q83389363 | ||
| Pulmonary thromboembolism as the initial manifestation in a child with antiphospholipid syndrome in the emergency department | Q83541690 | ||
| Pediatric cerebellar stroke associated with elevated titer of antibodies to β2-glycoprotein | Q83572548 | ||
| Factors associated with adherence to treatment in children and adolescents with chronic rheumatic diseases | Q85792745 | ||
| Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study | Q87375739 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 362 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in pediatrics | Q27725038 |
| P1476 | title | The Differences Between Childhood and Adult Onset Antiphospholipid Syndrome | |
| P478 | volume | 6 |
| Q91715407 | Pediatric antiphospholipid syndrome | cites work | P2860 |
Search more.